Definitive Healthcare Ownership
| DH Stock | USD 5.55 0.11 2.02% |
Definitive |
Definitive Stock Ownership Analysis
About 93.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.27. Some equities with similar Price to Book (P/B) outperform the market in the long run. Definitive Healthcare has Price/Earnings To Growth (PEG) ratio of 1.03. The entity recorded a loss per share of 3.09. The firm had not issued any dividends in recent years. Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts. Definitive Healthcare operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 676 people. To learn more about Definitive Healthcare Corp call Kevin Coop at 508 720 4224 or check out https://www.definitivehc.com.Besides selling stocks to institutional investors, Definitive Healthcare also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Definitive Healthcare's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Definitive Healthcare's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Definitive Healthcare Quarterly Liabilities And Stockholders Equity |
|
Definitive Healthcare Insider Trades History
Roughly 4.0% of Definitive Healthcare Corp are currently held by insiders. Unlike Definitive Healthcare's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Definitive Healthcare's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Definitive Healthcare's insider trades
Definitive Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Definitive Healthcare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Definitive Healthcare Corp backward and forwards among themselves. Definitive Healthcare's institutional investor refers to the entity that pools money to purchase Definitive Healthcare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2024-09-30 | 1 M | Goldman Sachs Group Inc | 2024-09-30 | 1 M | New York State Common Retirement Fund | 2024-12-31 | 771.8 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 741.2 K | Boothbay Fund Management, Llc | 2024-09-30 | 724.5 K | Bank Of America Corp | 2024-09-30 | 683.5 K | Citadel Advisors Llc | 2024-09-30 | 559.8 K | D. E. Shaw & Co Lp | 2024-09-30 | 548.2 K | Northern Trust Corp | 2024-09-30 | 481.7 K | Advent International Lp | 2024-12-31 | 62.5 M | Irenic Capital Management Lp | 2024-09-30 | 6.4 M |
Definitive Healthcare Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Definitive Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Definitive Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Definitive Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Definitive Healthcare Outstanding Bonds
Definitive Healthcare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Definitive Healthcare uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Definitive bonds can be classified according to their maturity, which is the date when Definitive Healthcare Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Definitive Healthcare Corporate Filings
| 13th of February 2025 Other Reports | ViewVerify | |
F4 | 4th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 16th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 12th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Definitive Healthcare Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Definitive Healthcare. If investors know Definitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.09) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets | Return On Equity |
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Definitive Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Definitive Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Definitive Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.